People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fluidigm Corp | — | Biotechnology | Series C | $111.0M | $3.1B | 2009 |
| Rennovia Inc | — | Other Technology | Series B | $81.0M | $60.9M | 2009 |
| Flexion Therapeutics Inc | — | Biotechnology | Series B | $40.0M | $793.8M | 2009 |
SAMUEL COLELLA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside SAMUEL COLELLA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Schwab | 1 | 16 |
| BRADLEY BOLZON | 1 | 10 |
| Heath Lukatch | 1 | 10 |
| SCOTT ROCKLAGE | 1 | 9 |
| John Young | 1 | 7 |
| Elaine Jones | 1 | 6 |
| Kevin Moore | 1 | 5 |
| JOHN A. YOUNG | 1 | 5 |
| Samuel D. Colella | 1 | 4 |
| Michael Hunkapiller | 1 | 4 |
| Gerrit Klaerner | 1 | 3 |
| Patrick S. Jones | 1 | 3 |
| Kurt Swogger | 1 | 2 |
| Arthur Fratamico | 1 | 2 |
| NEIL BODICK | 1 | 2 |
| Alan Milinazzo | 1 | 2 |
| ROBERT C. JONES | 1 | 2 |
| WILLIAM M. SMITH | 1 | 2 |
| MICHAEL CLAYMAN | 1 | 2 |
| Andrew McMillan | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.